0001733538-20-000003.txt : 20200131 0001733538-20-000003.hdr.sgml : 20200131 20200131131534 ACCESSION NUMBER: 0001733538-20-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200131 DATE AS OF CHANGE: 20200131 EFFECTIVENESS DATE: 20200131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tolerion, Inc. CENTRAL INDEX KEY: 0001733538 IRS NUMBER: 810881622 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-359489 FILM NUMBER: 20564377 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-795-5800 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001733538 Tolerion, Inc. 131 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 415-795-5800 DELAWARE None None Corporation true John Donovan 131 Oyster Point Blvd. Suite 400 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Sean Stalfort 131 Oyster Point Blvd. Suite 400 South San Francisco CA CALIFORNIA 94080 Director Paul Manning 131 Oyster Point Blvd. Suite 400 South San Francisco CA CALIFORNIA 94080 Director Lawrence Steinman 131 Oyster Point Blvd. Suite 400 South San Francisco CA CALIFORNIA 94080 Director Stephen Zachary 131 Oyster Point Blvd. Suite 400 South San Francisco CA CALIFORNIA 94080 Director James Stutz 131 Oyster Point Blvd. Suite 400 South San Francisco CA CALIFORNIA 94080 Executive Officer Scott Geyer 131 Oyster Point Blvd. Suite 400 South San Francisco CA CALIFORNIA 94080 Executive Officer Alexander Fleming 131 Oyster Point Blvd. Suite 400 South San Francisco CA CALIFORNIA 94080 Executive Officer Randolph Johnson 131 Oyster Point Blvd. Suite 400 South San Francisco CA CALIFORNIA 94080 Executive Officer Graeme Curie 131 Oyster Point Blvd. Suite 400 South San Francisco CA CALIFORNIA 94080 Executive Officer Biotechnology Decline to Disclose 06b false 2020-01-16 false true false 0 39999993 19999998 19999995 Series B-1 Preferred Stock and the underlying Common Stock issuable upon conversion thereof. false 4 0 0 0 false Tolerion, Inc. /s/ John Donovan John Donovan Chief Executive Officer 2020-01-31